Department of Cardiac Surgery, Friedrich-Alexander University, Erlangen-Nürnberg, Krankenhausstrasse 12, 91054 Erlangen, Germany.
Transpl Immunol. 2010 May;23(1-2):59-64. doi: 10.1016/j.trim.2010.04.003. Epub 2010 Apr 13.
Rodent models are a very helpful tool to investigate immunological mechanisms in allograft rejection. The aim of this study was to compare two different immunodeficient recipients in a humanized mouse model of arterial xenotransplantation in terms of reconstitution of the human immune system and rejection of the arterial graft.
Side branches of human mammary artery were transplanted as infrarenal aortic interposition grafts into C.B-17-SCID beige and C57BL/6-Rag2(-/-)gammac(-/-) recipients. 7days after surgery mice were reconstituted with 5x10(7) human peripheral blood mononuclear cells (hu PBMCs) and 30days after reconstitution mice were sacrificed and histologic analysis was performed. Peripheral blood and splenocytes were investigated by FACS and ELISA analysis to ensure engraftment of human CD45(+) cells.
Transplant arteriosclerosis developed in non-PBMC-reconstituted C.B-17-SCID beige mice (intimal proliferation: 36.31+/-4.37%), but significantly less in C57BL/6-Rag2(-/-) gammac(-/-) recipients (intimal proliferation: 12.26+/-5.21%). After reconstitution with 5x10(7) unfractionated human PBMCs both mouse strains showed intima proliferation 30days after reconstitution (C.B-17-SCID beige: 28.49+/-7.95% and C57BL/6-Rag2(-/-) gammac(-/-): 44.58+/-11.08%). Whereas only very few human CD45(+) cells were found in mouse blood and spleen of C.B-17-SCID beige mice, C57BL/6-Rag2(-/-) gammac(-/-) mice revealed a reliable reconstitution. In addition, levels of human IgG and IgM within the peripheral blood were markedly higher in C57BL/6-Rag2(-/-) gammac(-/-) recipients.
In this study we can show, that the use of C57BL/6-Rag2(-/-) gammac(-/-) mice may be advantageous compared to C.B-17-SCID beige recipients in a humanized mouse model of vessel transplantation.
啮齿动物模型是研究同种异体移植排斥反应中免疫机制的非常有用的工具。本研究的目的是比较两种不同的免疫缺陷受者在人源化小鼠动脉异种移植模型中,在重建人体免疫系统和排斥动脉移植物方面的差异。
将人乳内动脉的侧支作为肾下主动脉间置移植到 C.B-17-SCID beige 和 C57BL/6-Rag2(-/-) gammac(-/-)受者体内。手术后 7 天,用 5x10(7)个外周血单个核细胞(hu PBMCs)重建小鼠,重建后 30 天处死小鼠并进行组织学分析。通过流式细胞术和 ELISA 分析外周血和脾细胞,以确保人 CD45(+)细胞的植入。
未重建 PBMC 的 C.B-17-SCID beige 小鼠发生移植性动脉粥样硬化(内膜增生:36.31+/-4.37%),但 C57BL/6-Rag2(-/-) gammac(-/-)受者明显较少(内膜增生:12.26+/-5.21%)。用 5x10(7)个未分离的人 PBMC 重建后,两种小鼠品系在重建后 30 天均出现内膜增生(C.B-17-SCID beige:28.49+/-7.95%和 C57BL/6-Rag2(-/-) gammac(-/-):44.58+/-11.08%)。虽然在 C.B-17-SCID beige 小鼠的鼠血和鼠脾中只发现了极少数的人 CD45(+)细胞,但 C57BL/6-Rag2(-/-) gammac(-/-)小鼠显示出可靠的重建。此外,外周血中人 IgG 和 IgM 的水平在 C57BL/6-Rag2(-/-) gammac(-/-)受者中明显更高。
在这项研究中,我们可以表明,与 C.B-17-SCID beige 受者相比,在人源化小鼠血管移植模型中,使用 C57BL/6-Rag2(-/-) gammac(-/-)小鼠可能具有优势。